[1]青格乐图.步长脑心通胶囊治疗高原红细胞增多症40例[J].西部中医药,2012,25(12):63-64.
　QingGe Le-tu.BuChang NaoXinTong Capsule in the Treatment for 40 Cases of Altitude Erythrocytosis[J].Western Journal of Traditional Chinese Medicine,2012,25(12):63-64.
点击复制

步长脑心通胶囊治疗高原红细胞增多症40例
分享到：

《西部中医药》[ISSN:2096-9600/CN:62-1204/R]

卷:
25
期数:
2012年12期
页码:
63-64
栏目:
出版日期:
2012-12-15

文章信息/Info

Title:
BuChang NaoXinTong Capsule in the Treatment for 40 Cases of Altitude Erythrocytosis
文章编号:
1004-6852(2012)12-0063-02
作者:
青格乐图
格尔木市人民医院高原病科，青海 格尔木 816000
Author(s):
QingGe Le-tu
Department of Altitude Disease in Geermu Municipal People’s Hospital, Geermu 816000, China
关键词:
高原红细胞增多症; 步长脑心通胶囊; 红细胞压积
Keywords:
altitude erythrocytosis; BuChang NaoXinTong capsule;  hematocrit
分类号:
R555.1
文献标志码:
A
摘要:
目的：观察步长脑心通胶囊治疗高原红细胞增多症的临床疗效。方法：将80例高原红细胞增多症患者随机分为观察组、对照组各40例。2组均给予羟基脲治疗，观察组同时给予脑心通胶囊，3粒/次，3次/d。2组均以治疗1个月为1个疗程，治疗2个疗程后观察疗效。结果：治愈率观察组为77.50%，对照组为65.00%，2组相比有明显差异(P＜0.05)。总有效率观察组为97.50%，对照组为85.00%，2组相比有明显差异(P＜0.05)。血红蛋白、红细胞数、红细胞压积2组治疗后均明显下降，与治疗前相比差异具有统计学意义(P＜0.05)，且观察组下降较对照组明显(P＜0.05)。结论：步长脑心通胶囊治疗高原红细胞增多症疗效显著。
Abstract:
Objective: To observe clinical effects of BuChang NaoXinTong capsule in treating altitude erythrocytosis. Method: Eighty patients were randomized into the observation group and the control group. Both groups took hydroxycarbamide, meanwhile, the observation group NaoXinTong capsule, three pills once and three times each day. One course of therapy was one month, clinical effects were observed after two courses of treatment.Result: The cure rate of the observation group was 77.50% and that of the control group was 65.00%, the result showed there was significant difference between both groups (P＜0.05). Total effective rates of the observation group and thecontrolgroup were97.50%and 85.00%, theresultshowed thattherewassignificantdifference (P＜ 0.05).Both groups decreased remarkably after treating in hemoglobin, red blood cell count and hematocrit, compared with before treating it showed statistical meaning (P＜0.05), the decrease of the observation group was more significant than that of the control group (P＜0.05). Conclusion:BuChang NaoXinTong capsule shows notable curative effects in treating altitude erythrocytosis.

参考文献/References:

［1］ 张之南．血液病诊断及疗效标准［M］.2 版.北京：科学出版社，1998：88．［2］ 白萍，赵泽文，刘晓晴，等.高原红细胞增多症病因发病机制与红细胞膜特征［J］.临床军医杂志，2003，31(6)：89-91．［3］ 中华医学会高原医学分会.关于统一使用慢性高原(山)病“青海标准”的决定［J］.高原医学杂志，2007，17(1)：1．［4］ 吉建江.低分子肝素、阿司匹林、丹参滴丸对高原红细胞增多症的疗效观察［J］.高原医学杂志，2009，19(2)：34-35．［5］ 邹萍.内科学［M］.北京：人民卫生出版社，2005：781-785. ［6］ 国际高原医学会慢性高原病专家小组.慢性高原病青海诊断标准［J］.青海医学院学报，2005，26(1)：3-5. ［7］ 冯建明，沈括.慢性高原病的诊治进展［J］.中国实用内科杂志，2007，27(11)：75-77. ［8］ 尹艳，孙凤.真性红细胞增多症中医治疗近况［J］.中医药信息，2000，17（1）：14-15. ［9］ 孙新甫.慢性高原红细胞增多症的发病机制及病理变化［J］.中华血液学杂志，1996，17(2)：109-110. ［10］赵步长，伍海勤，赵涛.脑心同治［M］.北京：人民卫生出版社，2006：16-20.

相似文献/References:

[1]邴雅珺.通脑丸干预脑动脉硬化症慢性脑缺血损伤的作用机制研究*[J].西部中医药,2013,26(06):6.
　BING Yajun.Study on the Mechanism of TongNaoW an Intervening the Injury of Chronic Cerebral Ischemia Induced by Cerebral Arteriosclerosis[J].Western Journal of Traditional Chinese Medicine,2013,26(12):6.
[2]鲁梦倩,尼玛次仁,于天源△,等.藏药佐木阿汤对高原红细胞增多症模型大鼠心肌细胞线粒体DNA的影响[J].西部中医药,2016,29(04):10.
　LU Mengqian,NIMA Ciren,YU Tianyuan,et al.Influence of Tibetan Medicine ZuoMuA Tang on Myocardial mtDNA of HAPC Rat Model[J].Western Journal of Traditional Chinese Medicine,2016,29(12):10.

备注/Memo

备注/Memo:
收稿日期：2012-11-20 作者简介：青格乐图(1974—)，男，硕士学位，副主任医师。研究方向：心血管疾病、高原病的中西医结合诊治。
更新日期/Last Update: 1900-01-01